Versant Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-9
| Closed | -$2.96K | – | 2525 |
|
|
2024
Q4 | $2.96K | Buy |
+9
| New | +$2.96K | ﹤0.01% | 1962 |
|
|
2024
Q3 | – | Sell |
-11
| Closed | -$3K | – | 2017 |
|
|
2024
Q2 | $3K | Buy |
11
+7
| +175% | +$1.91K | ﹤0.01% | 1384 |
|
|
2024
Q1 | $1.38K | Hold |
4
| – | – | ﹤0.01% | 1460 |
|
|
2023
Q4 | $1.29K | Sell |
4
-8
| -67% | -$2.58K | ﹤0.01% | 1428 |
|
|
2023
Q3 | $4.3K | Buy |
12
+9
| +300% | +$3.23K | ﹤0.01% | 1034 |
|
|
2023
Q2 | $1.14K | Sell |
3
-14
| -82% | -$5.31K | ﹤0.01% | 1554 |
|
|
2023
Q1 | $8.14K | Sell |
17
-9
| -35% | -$4.31K | ﹤0.01% | 774 |
|
|
2022
Q4 | $10.9K | Buy |
26
+14
| +117% | +$5.89K | ﹤0.01% | 644 |
|
|
2022
Q3 | $5K | Buy |
+12
| New | +$5K | ﹤0.01% | 824 |
|
|
2022
Q1 | – | Sell |
-4
| Closed | -$3K | – | 1459 |
|
|
2021
Q4 | $3K | Hold |
4
| – | – | ﹤0.01% | 1013 |
|
|
2021
Q3 | $3K | Buy |
+4
| New | +$3K | ﹤0.01% | 1013 |
|
|
2019
Q2 | – | Sell |
-5
| Closed | -$1K | – | 1415 |
|
|
2019
Q1 | $1K | Hold |
5
| – | – | ﹤0.01% | 1420 |
|
|
2018
Q4 | $1K | Hold |
5
| – | – | ﹤0.01% | 1334 |
|
|
2018
Q3 | $1K | Hold |
5
| – | – | ﹤0.01% | 1386 |
|
|
2018
Q2 | $1K | Hold |
5
| – | – | ﹤0.01% | 1367 |
|
|
2018
Q1 | $1K | Hold |
5
| – | – | ﹤0.01% | 1354 |
|
|
2017
Q4 | $1K | Hold |
5
| – | – | ﹤0.01% | 1399 |
|
|
2017
Q3 | $1K | Hold |
5
| – | – | ﹤0.01% | 1315 |
|
|
2017
Q2 | $1K | Hold |
5
| – | – | ﹤0.01% | 1305 |
|
|
2017
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 1436 |
|
|
2016
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 1390 |
|
|
2016
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 1377 |
|
|
2016
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 1341 |
|
|
2016
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 1337 |
|
|
2015
Q4 | $0 | Buy |
+5
| New | – | ﹤0.01% | 1342 |
|